A dvances in the field of tissue engineering and regenerative medicine, as indicated by the clinical approval of skin, cartilage, vascular grafts, and bladder, have shown that simple connective tissues can be produced in vitro and used to treat patients. 1À3 Most engineered tissues have been generated by seeding cells in porous scaffolds derived from natural and synthetic polymers. These scaffolds create a three-dimensional (3D) environment that promotes cellular attachment, migration, proliferation, and differentiation. Despite these advances, a number of technical challenges are currently preventing the development of more complex organs such as the liver, heart, and kidney. 4 These include the inability to reproduce the physical (substrate stiffness, architecture) and chemical (cytokines, growth factors, cellÀcell, cellÀ matrix) interactions surrounding the cells in vivo and the lack of a suitable blood vessel supply to ensure cell function in thick tissues. The structure and organization of the extracellular matrix (ECM) components and the interactions between the cellular and soluble factors found in tissue surroundings are known to play a significant role in the physiologic function of tissues and organs. Therefore, it is important that scaffolds recreate this microenvironment to engineer tissues with appropriate function. However, many current approaches aiming at tissue and organ regeneration are not designed for optimized performance at such length scales. The challenge is to develop technologies that will enable the engineering of scalable constructs reproducing the cellular microenvironment found in vivo. These approaches, which will be of use for generating large, functional, and vascularized 3D structures, should enable control of the arrangement of microscopic structures, which is essential to achieve the adequate level of functionality in engineered tissues. Current strategies are moving toward bioinspired methods to produce physiologically relevant tissues and organs. Major efforts are directed toward the generation of increasingly sophisticated materials that can mimic native tissues with respect to both architecture and functionality. 5 Microscale technologies are currently studied as potential tools for addressing this issue. The cell-seeded scaffold, which has led to significant advances over the past three decades, is currently shifting from empirical approaches to precisely engineered systems. 6 Techniques such as soft 
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Whitesides and co-workers have pioneered the mesoscale assembly of millimeter-scale objects into precisely defined 2D and 3D structures using the minimization of interfacial free energy at the liquidÀliquid interface. 18, 19 Inspired by these findings, we have developed a bottom-up approach to direct the assembly of cell-laden microgels to form 3D tissue constructs with tunable microarchitecture and complexity. 16 These cell-containing microgels can be engineered to regulate the cellular environment in a specific and "intelligent" fashion.
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By using microtechnologies, it is possible to create patterns of multiple cell types as well as gradients of chemicals and signaling molecules across the hydrogel materials, thus enabling regulation of cell behavior within the scaffolding material. 6, 20, 24 Moreover, a range of fabrication methods can also be used to control the shape of the resulting microgels ( Figure 1A ) and to generate microscale units in a high-throughput fashion. 25 Therefore, the directed assembly of cell-laden microscale hydrogels may be useful in generating bioengineered functional tissues with precisely engineered physical, chemical, and biological properties.
In previous studies, our group has shown that the assembly of microgel units can be driven by the tendency of multiphase liquid systems to minimize surface area and free energy. 16 This thermodynamically driven assembly technique relies on the hypothesis that the hydrophilic properties of microgels, combined with the hydrophobic properties of the medium, can be used as the driving force to generate 3D structures. 26 Mechanical stability of these assemblies can be controlled by a secondary crosslinking reaction using light exposure. This scalable technique can be used to generate biomimetic, 3D tissue constructs. To create more complex tissues and organs displaying physiologic morphology, modular approaches are moving toward the directed assembly of functional microunits ( Figure 1BÀD ). 27 For example, lock-and-key-shaped microgels can assemble in a more predictable manner within a multiphase reactor system to generate 3D structures. It is envisioned that once the engineered building blocks are assembled in an ordered state, they will be remodeled by the cells, integrate with the host vasculature, and function as an organ substitute. 28 The main limitation of self-assembly approaches that rely on liquidÀ air and hydrophilicÀhydrophobic interactions is the restricted number of shapes that can be generated at the interfaces of the different phases. The packing process of microgels requires hierarchical and
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PERSPECTIVE organizational driving forces that enable precise microgel placement and assembly, which are essential for recreating biomimetic tissue complexity. To address this issue, we have developed a technique whereby a solid surface acts as a template to direct the assembly process. 29 In this system, the solid surface of the template confines and restricts the microgels into a well-defined structure (Figure 2A,B) . Due to the capillary forces of the prepolymer solution, microgels are able to pack densely around the surface of the template on which they are placed. The current challenge regarding this approach remains the ability to generate anisotropic 3D structures since the arrangement of units having distinct differences in their properties remains difficult. Since self-assembly processes are relying on physical and thermodynamic energy balances between states or phases, the optimal assembly of the microunits will depend on the properties of the material, as well as the nature of the driving forces used to trigger the aggregation of the building blocks. From a tissue engineering perspective, the assembly and packing of the microgels will need to be performed following stringent requirements. The control of chemical and physical interactions between the microgels will be essential for the development of desirable tissue function and stability of self-assembled hydrogel structures. 30 The development of modified interfaces using electrostatic charges or adhesion motifs could lead to more efficient bonding between the microgels, resulting in increased cohesion and stronger load-bearing capabilities. Consequently, the optimal physiologic performance of 3D engineered tissues will depend on the driving forces and the interfacial phenomena used to build these 3D structures because they will enable the fabrication of essential features such as the precise branching of perfusable vascular structure following microgel assembly.
Microengineering of 3D Branched Vasculature. A key limiting factor in the clinical translation of tissue engineering technologies is the inability to generate functional and thick tissues due to the absence of vascular structures in engineered tissues. Recent findings have demonstrated that endothelial cells involved in the angiogenic process not only form passive conduits to deliver nutrients and oxygen but also establish an instructive niche responsible for paracrine signaling stimulating organ regeneration, thus highlighting the importance of vascular structures in engineered tissues. 31 Previous strategies aiming at the engineering of vasculature have relied on the presence of endothelial cells, seeded or cocultured in the scaffold, to induce the release of growth factors and promote angiogenesis. This method was found to be adequate to form capillary-like structures that will ultimately connect with the host vasculature once the tissue is implanted in vivo. 
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However, the amount of time required to generate proper vascularization and to achieve adequate transport of nutrients considerably reduces the efficiency of producing vascularized tissues and often leads to cell death and tissue necrosis. 4 Thus, this solution has not been able to generate organ-scale constructs in vitro.
Microfabrication technologiesmore specifically, microfluidic systems-have emerged as promising approaches to generate physiologically relevant vascular structures into tissue scaffolds. 35 These approaches mostly rely on engineered channel networks fabricated in biodegradable polymers. 36À40 However, most of the vascularized systems are built using top-down approaches and are generally found in planar or stacked 2D structures. 41 Although previous work has shown that microscale cell-laden channels can be engineered in vitro, it is particularly difficult to branch multidimensional channels consecutively in 3D. 42 Techniques such as direct ink writing and omnidirectional printing have recently been developed to create 3D vascular structures. 43, 44 Despite enormous potential, these approaches will require further improvement to enable the control of the tissue structures surrounding the vascular channels. However, modular assembly techniques can be rationally engineered using cell-laden microgels produced by photolithography. Photolithography and self-assembling systems represent novel approaches to building biomimetic vascular-like structures for tissue engineering and in vitro models. Our group has developed a simple approach to direct the assembly of cell-laden microengineered hydrogels embedded with vascularlike microchannels having circular lumens. 45 The sequential assembly of hydrophilic hydrogels, performed in a biphasic reactor, resulted in a 3D structure with multilevel interconnected branching vasculature ( Figure 2C ). In addition to the directed assembly of the microgels, smooth muscle cells and endothelial cells were encapsulated in the 3D construct and remained viable for an extended period of time. 45 Compared to previous work, this sequential assembly technique of vascularized units is a step forward in our ability to control the relative spatial arrangement of the building blocks and the architecture of the 3D assembly. 16, 17 In a continuation of this work, the long-term perfusion of these capillary networks will be investigated. PERSPECTIVE integrity, will benefit from the sequential assembly process enabling the fabrication of 3D constructs containing multiple cell types with defined architectures and functions. Given these results, it appears that modular tissue engineering may be useful in controlling the microenvironment of large and vascularized 3D structures, more specifically for building scaffolds requiring cellscale precision ( Figure 2D ).
Microscale Bioassays and Validation Tools for Engineered Tissue Functionality.
It has been shown that individual cell-containing microgels can be fabricated and hierarchically assembled into 3D structures, leading to organized and branched architectures, 16, 45 However, the characterization of the physiologic functionality of these cell-laden microgels and the macroscale structure resulting from their assembly still needs to be clearly demonstrated. To generate functional tissues, individual units will have to display appropriate properties prior to their incorporation into the 3D structure. The assembly may also have to demonstrate adequate physiologic functionality, as well as perfusion capabilities and structural strength. The development of new classes of biosensors that will assess the functionality of both the microgels and their assembly will be of tremendous importance in enabling this technology. Microscale technologies have been used to develop numerous tools to investigate cellÀcell and cellÀmicroenviron-ment interactions in vitro. 6 It has also been shown that microfabricated systems can be used as sensors in microdevices. 46 
CONCLUSIONS AND PROSPECTS
Although tissue engineering has been described as the next generation of available treatment to replace and to regenerate organs, this technology has not yet fully realized its potential. This can be explained by the fact that engineered tissues previously developed were simple and lacked the complexity associated with many native tissues. Organ function and regeneration is highly dependent on proper spatial placement and arrangement of multiple single units, as well as on inductive and adequate signaling throughout the structure. Recent advances in microtechnologies have increased our capability to engineer functional tissues for therapeutic applications. The design of new methods that enable the directed self-assembly of microgels into 3D configurations composed of microfluidic branched structures has shown significant potential for tissue engineering applications. Moreover, the emergence of modular assembly is currently enabling the development of a new class of functional and instructive engineered tissues. The success of these novel techniques promises to address current challenges, such as nutrient and oxygen PERSPECTIVE transport and vascularization, and will ultimately translate into functional and readily available organs for transplantation. In addition, microtechnologies may also lead to the development of new biosensors and biomimetic microdevices. This convergence of multiple research fields, ranging from biomaterials to microfabrication and stem cell biology, is highly promising in leading to the generation of engineered biological systems for clinical applications.
